NR3C2 and plasma cell myeloma: In our case, Spi addition partially suppressed Dex-induced GR–MR heterodimer formation and abolished Dex-induced MR–MR homodimerization, which may form a molecular basis to support differential gene and protein expression profiles with enhanced anti-myeloma outcomes compared to Dex.